Novo Nordisk Receives Boost on $2.34B Italian Factory

Novo Nordisk A/S (NYSE:NVO) is one of the 10 best defensive stocks to buy in a volatile market. On July 7, the company received a significant boost in its proposed $2.34 billion investment in a factory in Rome, Italy.

Novo Nordisk Receives Boost on $2.34B Italian Factory

A researcher in a lab coat working with a microscope, studying a biopharmaceutical drug.

Italian authorities have already appointed Francesco Rocca as president of the Lazio region, which includes Rome. He is responsible for accelerating projects related to the Novo Nordisk facility. The Lazio region has already approved upgrades for road links worth more than €2.9 million.

The proposed facility is designed to produce weight loss and diabetes medications, with production scheduled to commence in late 2026 or early 2027. The Italian government has already given Novo Nordisk the green light to upgrade the capacity of its Anagni site.

While we acknowledge the potential of NVO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Materials Stocks to Buy According to Analysts and 10 Best Organic Food and Farming Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.